netFormulary
 Report : A-Z HCD items in Formulary 17/06/2021 21:43:47
[Back]
 
Section Status HCD Name
10.01.03 Formulary Cancer Drugs Fund Abatacept 
08.01.05 Formulary Cancer Drugs Fund Abemaciclib Verzenios
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Zytiga
08.01.05 Formulary Cancer Drugs Fund Acalabrutinib 
01.05.03 Formulary Cancer Drugs Fund Adalimumab 
10.01.03 Formulary Cancer Drugs Fund Adalimumab 
13.05.03 Formulary Cancer Drugs Fund Adalimumab 
08.01.05 Formulary Cancer Drugs Fund Afatinib Giotrif
08.01.05 Non Formulary Cancer Drugs Fund Aflibercept Zaltrap
11.08.02 Formulary Cancer Drugs Fund Aflibercept 
09.08.01 Restricted Use Cancer Drugs Fund Agalsidase Alfa and Beta Fabrazyme
09.08.01 Restricted Use Cancer Drugs Fund Agalsidase Alfa and Beta Replagal
08.02.04 Non Formulary Cancer Drugs Fund Aldesleukin Proleukin
08.01.05 Formulary Cancer Drugs Fund Alectinib Alecensa
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab Lemtrada
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab MabCampath
09.08.01 Restricted Use Cancer Drugs Fund Alglucosidase Alfa Myozyme
13.05.01 Formulary Cancer Drugs Fund Alitretinoin 
02.05.01 Non Formulary Cancer Drugs Fund Ambrisentan 
05.02 Formulary Cancer Drugs Fund Amphotericin AmBisome
10.01.03 Formulary Cancer Drugs Fund Anakinra 
05.02.04 Formulary Cancer Drugs Fund Anidulafungin Ecalta
08.02.02 Non Formulary Cancer Drugs Fund Antithymocyte immunoglobulin (rabbit)  Thymoglobuline
10.01.03 Formulary Cancer Drugs Fund Apremilast rheumatology
13.05.03 Formulary Cancer Drugs Fund Apremilast Dermatology
08.01.05 Formulary Cancer Drugs Fund Arsenic Trioxide Trisenox
10.02 Formulary Cancer Drugs Fund Ataluren 
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq
08.02 Non Formulary Cancer Drugs Fund Autologous anti-CD19-transduced CD3+ cells Tecartus
08.01.05 Formulary Cancer Drugs Fund Avelumab Bavencio
08.01.05 Formulary Cancer Drugs Fund Axitinib Inlyta
08.01.03 Formulary Cancer Drugs Fund Azacitidine Vidaza
05.01.02.03 Restricted Use Cancer Drugs Fund Aztreonam nebuliser solution Cayston
10.01.03 Formulary Cancer Drugs Fund Baricitinib 
13.05.03 Formulary Cancer Drugs Fund Baricitinib Olumiant
08.02.02 Formulary Cancer Drugs Fund Basiliximab Simulect
08.01 Non Formulary Cancer Drugs Fund Begelomab Begedina
08.02.02 Non Formulary Cancer Drugs Fund Belatacept Nulojix
10.01 Formulary Cancer Drugs Fund Belimumab 
02.12 Formulary Cancer Drugs Fund Bempedoic acid nilemdo
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.01 Non Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Binimetinib Mektovi
08.01.02 Formulary Cancer Drugs Fund Bleomycin 
08.02 Formulary Cancer Drugs Fund Blinatumomab Blincyto
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
02.05.01 Formulary Cancer Drugs Fund Bosentan 
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
08.01.05 Formulary Cancer Drugs Fund Brigatinib Alunbrig
11.08.02 Formulary Cancer Drugs Fund Brolucizumab Beovu
08.01.01 Formulary Cancer Drugs Fund Busulfan 
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cabometyx Cometriq
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cometriq
08.02.04 Non Formulary Cancer Drugs Fund Canakinumab Ilaris
08.01.03 Formulary Cancer Drugs Fund Capecitabine 
08.01.05 Formulary Cancer Drugs Fund Carboplatin 
08.01.05 Formulary Cancer Drugs Fund Carboplatin Paraplatin
08.01.05 Formulary Cancer Drugs Fund Carfilzomib Kyprolis
08.01.01 Non Formulary Cancer Drugs Fund Carmustine BiCNU
08.01.01 Formulary Cancer Drugs Fund Carmustine 
05.02.04 Formulary Cancer Drugs Fund Caspofungin 
08.01.05 Formulary Cancer Drugs Fund Ceritinib Zykadia
10.01.03 Formulary Cancer Drugs Fund Certolizumab Pegol 
13.05.03 Formulary Cancer Drugs Fund Certolizumab pegol 
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux
08.01.01 Formulary Cancer Drugs Fund Chlorambucil 
08.02.02 Formulary Cancer Drugs Fund Ciclosporin 
09.05.01.02 Formulary Cancer Drugs Fund Cinacalcet 
08.01.05 Formulary Cancer Drugs Fund Cisplatin 
08.01.03 Formulary Cancer Drugs Fund Cladribine LeustakLitak
08.02.04 Non Formulary Cancer Drugs Fund Cladribine Mavenclad
08.01.03 Formulary Cancer Drugs Fund Clofarabine 
08.02.04 Non Formulary Cancer Drugs Fund Cobimetinib Cotellic
05.01.07 Formulary Cancer Drugs Fund Colistimethate for nebulisation Colomycin
08.01.05 Formulary Cancer Drugs Fund Crisantaspase Erwinase
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori
08.01.01 Formulary Cancer Drugs Fund Cyclophosphamide 
08.01.03 Formulary Cancer Drugs Fund Cytarabine Depocyte
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar
08.01.05 Formulary Cancer Drugs Fund Dacarbazine 
08.02.02 Non Formulary Cancer Drugs Fund Daclizumab Zenapax
08.01.05 Formulary Cancer Drugs Fund Dacomitinib Vizimpro
08.01.02 Non Formulary Cancer Drugs Fund Dactinomycin Cosmegen Lyovac
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex
09.01.03 Formulary Cancer Drugs Fund Darbepoetin Alfa Aranesp
08.03.04.02 Formulary Cancer Drugs Fund Darolutamide Nubeqa
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel
08.01.02 Formulary Cancer Drugs Fund Daunorubicin 
20 Non Formulary Cancer Drugs Fund DAUNORUBICIN saline pre-filled syringe 
08.01.03 Non Formulary Cancer Drugs Fund Decitabine Dacogen
09.01.03 Formulary Cancer Drugs Fund Deferasirox Exjade
20 Non Formulary Cancer Drugs Fund DEFIBROTIDE Capsules 400 mg 
02.11 Non Formulary Cancer Drugs Fund Defibrotide Injection 200 mg 
08.03.04.02 Formulary Cancer Drugs Fund Degarelix Firmagon
06.06.02 Formulary Cancer Drugs Fund Denosumab Prolia
06.06.02 Formulary Cancer Drugs Fund Denosumab XGEVA
09.01.03 Formulary Cancer Drugs Fund Desferrioxamine Mesilate Desferal
11.04.01 Formulary Cancer Drugs Fund Dexamethasone intravitreal implant 
08.01 Formulary Cancer Drugs Fund Dexrazoxane Savene
02.01.01 Formulary Cancer Drugs Fund Digoxin specific antibody fragments 
18 Non Formulary Cancer Drugs Fund Digoxin specific antibody fragments Digifab
08.02.04 Formulary Cancer Drugs Fund Dimethyl fumarate Tecfidera
13.05.02 Formulary Cancer Drugs Fund Dimethyl Fumarate  
08.02.04 Non Formulary Cancer Drugs Fund Dinutuximab Unituxin
08.01.05 Formulary Cancer Drugs Fund Docetaxel Taxotere
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx ,
Myocet
08.01.05 Formulary Cancer Drugs Fund Dupilumab 
12.02.02 Non Formulary Cancer Drugs Fund Dupilumab 
08.02.04 Non Formulary Cancer Drugs Fund Eculizumab Soliris
09.01.03 Non Formulary Cancer Drugs Fund Eculizumab 
09.01.04 Formulary Cancer Drugs Fund Eltrombopag 
08.01.05 Formulary Cancer Drugs Fund Encorafenib Braftovi
08.01.05 Formulary Cancer Drugs Fund Entrectinib 
08.03.04.02 Formulary Cancer Drugs Fund Enzalutamide Xtandi
08.01.02 Formulary Cancer Drugs Fund Epirubicin 2mg/ml
09.01.03 Formulary Cancer Drugs Fund Epoetin alfa Eprex
09.01.03 Formulary Cancer Drugs Fund Epoetin beta NeoRecormon
02.08.01 Formulary Cancer Drugs Fund Epoprostenol 
20 Non Formulary Cancer Drugs Fund Eptotermin Alfa  Osigraft
04.07.04.02 Formulary Cancer Drugs Fund Erenumab Aimovig
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven
08.01.05 Non Formulary Cancer Drugs Fund Erlotinib Tarceva
08.01.05 Formulary Cancer Drugs Fund Erlotinib Tarceva
08.01.05 Non Formulary Cancer Drugs Fund Erlotinib Tarceva
10.01.03 Formulary Cancer Drugs Fund Etanercept Rheumatology
13.05.03 Formulary Cancer Drugs Fund Etanercept 
05.01.09 Restricted Use Cancer Drugs Fund Ethambutol 
08.01.04 Formulary Cancer Drugs Fund Etoposide Etopophos Vepesid
08.01.05 Formulary Cancer Drugs Fund Everolimus Afinitor
08.01.05 Formulary Cancer Drugs Fund Everolimus Votubia
08.02.02 Non Formulary Cancer Drugs Fund Everolimus Certican
02.11 Restricted Use Cancer Drugs Fund Factor IX Fraction, Dried 
02.11 Restricted Use Cancer Drugs Fund Factor VIII Fraction, Dried 
02.11 Restricted Use Cancer Drugs Fund Factor XIII Fraction, Dried 
08.02.04 Non Formulary Cancer Drugs Fund Fampridine 
10.01.03 Formulary Cancer Drugs Fund Filgotinib  Jyseleca
09.01.06 Formulary Cancer Drugs Fund Filgrastim 
08.02.04 Formulary Cancer Drugs Fund Fingolimod 
08.01.03 Formulary Cancer Drugs Fund Fludarabine Phosphate Fludara
11.04.01 Formulary Cancer Drugs Fund Fluocinolone intravitreal implant 
08.01.03 Formulary Cancer Drugs Fund Fluorouracil 
18 Non Formulary Cancer Drugs Fund Fomepizole 
05.03.02.02 Formulary Cancer Drugs Fund Ganciclovir 
08.01.05 Formulary Cancer Drugs Fund Gefitinib Iressa
08.01.03 Formulary Cancer Drugs Fund Gemcitabine Gemzar
08.02.03 Formulary Cancer Drugs Fund Gemtuzumab Mylotarg
08.01.05 Formulary Cancer Drugs Fund Gilteritinib 
08.02.04 Formulary Cancer Drugs Fund Glatiramer Acetate Copaxone
18 Non Formulary Cancer Drugs Fund Glucarpidase Carboxypeptidase
01.05.03 Formulary Cancer Drugs Fund Golimumab Gastroenterology
10.01.03 Formulary Cancer Drugs Fund Golimumab 
08.03.04.01 Formulary Cancer Drugs Fund Goserelin Zoladex
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
03.04.03 Formulary Cancer Drugs Fund Icatibant 
08.01.02 Formulary Cancer Drugs Fund Idarubicin Zavedos
11.08 Non Formulary Cancer Drugs Fund Idebenone Raxone
08.01.05 Formulary Cancer Drugs Fund Idelalisib Zydelig
08.01.01 Formulary Cancer Drugs Fund Ifosfamide 
02.05.01 Formulary Cancer Drugs Fund Iloprost injection  
02.05.01 Formulary Cancer Drugs Fund Iloprost nebules 
08.01.05 Formulary Cancer Drugs Fund Imatinib Gilvec
09.08.01 Restricted Use Cancer Drugs Fund Imiglucerase Cerezyme
01.05.03 Formulary Cancer Drugs Fund Infliximab 
08.02 Non Formulary Cancer Drugs Fund Infliximab 
10.01.03 Formulary Cancer Drugs Fund Infliximab 
13.05.03 Formulary Cancer Drugs Fund Infliximab 
08.02.04 Formulary Cancer Drugs Fund Interferon Alfa 
08.02.04 Formulary Cancer Drugs Fund Interferon Alfa Roferon-A
08.02.04 Formulary Cancer Drugs Fund Interferon Beta Avonex
08.02.04 Formulary Cancer Drugs Fund Interferon Beta Rebif
08.02.04 Formulary Cancer Drugs Fund Interferon Beta Betaferon
08.02.04 Formulary Cancer Drugs Fund Interferon beta Extavia
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy
08.01.05 Formulary Cancer Drugs Fund Irinotecan Hydrochloride 
08.01.05 Formulary Cancer Drugs Fund Irinotecan hydrochloride trihydrate  Onivyde
08.02 Formulary Cancer Drugs Fund Isatuximab Sarclisa
05.02 Non Formulary Cancer Drugs Fund Isavuconazole Cresemba
05.01.09 Restricted Use Cancer Drugs Fund Isoniazid 
03.07 Non Formulary Cancer Drugs Fund Ivacaftor 
03.07 Non Formulary Cancer Drugs Fund Ivacaftor with Lumacaftor Orkambi
03.07 Non Formulary Cancer Drugs Fund Ivacaftor with Tezacaftor Symkevi
03.07 Non Formulary Cancer Drugs Fund Ivacaftor with Tezacaftor and Elexacaftor Kaftrio
08.01.05 Formulary Cancer Drugs Fund Ixazomib Ninlaro
13.05.03 Formulary Cancer Drugs Fund Ixekizumab dermatology
05.03.03.01 Formulary Cancer Drugs Fund Lamivudine 
08.03.04.03 Formulary Cancer Drugs Fund Lanreotide Somatuline Autogel
08.03.04.03 Formulary Cancer Drugs Fund Lanreotide Somatuline LA
09.05.02.02 Formulary Cancer Drugs Fund Lanthanum Fosrenol
09.05.02.02 Formulary Cancer Drugs Fund Lanthanum 
08.01.05 Non Formulary Cancer Drugs Fund Lapatinib Tyverb
08.02.04 Formulary Cancer Drugs Fund Lenalidomide  Revlimid
09.01.06 Formulary Cancer Drugs Fund Lenograstim 
08.01.05 Formulary Cancer Drugs Fund Lenvatinib Lenvima
08.03.04.02 Formulary Cancer Drugs Fund Leuprorelin Acetate Prostap SR
08.03.04.02 Formulary Cancer Drugs Fund Leuprorelin Acetate Prostap 3
09.08.01 Formulary Cancer Drugs Fund Levocarnitine Carnitor
08.01.01 Formulary Cancer Drugs Fund Lomustine 
08.01.05 Formulary Cancer Drugs Fund Lorlatinib 
02.05.01 Formulary Cancer Drugs Fund Macitentan 
03.07 Formulary Cancer Drugs Fund Mannitol inhalation 
08.01.01 Formulary Cancer Drugs Fund Melphalan 
11.99.99.99 Non Formulary Cancer Drugs Fund Mercaptamine hydrochloride 0.55% viscous eye drops  
08.01.03 Formulary Cancer Drugs Fund Mercaptopurine Puri-Nethol Xaluprine
08.01.03 Formulary Cancer Drugs Fund Methotrexate 
05.02.04 Formulary Cancer Drugs Fund Micafungin Mycamine
09.08.01 Restricted Use Cancer Drugs Fund Migalastat Galafold
09.08.01 Restricted Use Cancer Drugs Fund Miglustat Zavesca
08.01.02 Formulary Cancer Drugs Fund Mitoxantrone (Mitozantrone) Onkotrone
08.02.01 Formulary Cancer Drugs Fund Mycophenolate Mofetil 
08.02.01 Formulary Cancer Drugs Fund Mycophenolic acid Myfortic
08.02.04 Formulary Cancer Drugs Fund Natalizumab Tysabri
08.01.05 Non Formulary Cancer Drugs Fund Necitumumab Portrazza
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance
08.01.05 Formulary Cancer Drugs Fund Neratinib Nerlynx
08.01.05 Formulary Cancer Drugs Fund Nilotinib Tasigna
03.11 Formulary Cancer Drugs Fund Nintedanib Ofev
03.11 Formulary Cancer Drugs Fund Nintedanib Vargatef
08.02.04 Formulary Cancer Drugs Fund Niraparib Zejula
20 Non Formulary Cancer Drugs Fund Nitazoxanide 
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo
14.05.01 Restricted Use Cancer Drugs Fund Normal immunoglobulin for Intravenous use 
01.09.01 Formulary Cancer Drugs Fund Obeticholic acid Ocaliva
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab Gazyvaro
11.08.02 Formulary Cancer Drugs Fund Ocriplasmin Jetrea
08.03.04.03 Formulary Cancer Drugs Fund Octreotide Sandostatin Lar
08.03.04.03 Formulary Cancer Drugs Fund Octreotide Sandostatin
08.02.04 Formulary Cancer Drugs Fund Olaparib Lynparza
03.04.02 Formulary Cancer Drugs Fund Omalizumab Xolair
08.02.04 Formulary Cancer Drugs Fund Osimertinib Tagrisso
08.01.05 Formulary Cancer Drugs Fund Oxaliplatin 
08.01.05 Formulary Cancer Drugs Fund Paclitaxel 
08.03.04.01 Formulary Cancer Drugs Fund Palbociclib Ibrance
05.03.05 Formulary Cancer Drugs Fund Palivizumab Synagis
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.05 Formulary Cancer Drugs Fund Panobinostat Farydak
06.05 Non Formulary Cancer Drugs Fund Pasireotide 
08.01.05 Formulary Cancer Drugs Fund Pazopanib Votrient
08.01 Formulary Cancer Drugs Fund Pegaspargase Oncaspar
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa ViraferonPeg
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa Pegasys
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa PegIntron
08.02.04 Formulary Cancer Drugs Fund Peginterferon Beta-1a Plegridy
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.02.04 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta
08.01.05 Formulary Cancer Drugs Fund Pentostatin Nipent
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta
03.11 Formulary Cancer Drugs Fund pirfenidone Esbriet
08.01.02 Formulary Cancer Drugs Fund Pixantrone Pixuvri
09.01.07 Non Formulary Cancer Drugs Fund Plerixafor Mozobil
08.01.05 Formulary Cancer Drugs Fund Polatuzumab vedotin Polivy
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig
05.02 Formulary Cancer Drugs Fund Posaconazole (IV) Noxafil
05.02 Formulary Cancer Drugs Fund Posaconazole (oral) Noxafil
08.01.05 Formulary Cancer Drugs Fund Procarbazine 
02.11 Formulary Cancer Drugs Fund Protein C Concentrate 
05.01.09 Restricted Use Cancer Drugs Fund Pyrazinamide  
08.03.04.02 Non Formulary Cancer Drugs Fund Radium-223 dichloride 
08.01.05 Formulary Cancer Drugs Fund Ramucirumab Cyramza
11.08.02 Formulary Cancer Drugs Fund Ranibizumab 
10.01.04 Formulary Cancer Drugs Fund Rasburicase 
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga
05.03.05 Formulary Cancer Drugs Fund Ribavirin 
05.01.07 Formulary Cancer Drugs Fund Rifaximin 
05.01.07 Non Formulary Cancer Drugs Fund Rifaximin 
04.09.03 Formulary Cancer Drugs Fund Riluzole Rilutek
10.02 Non Formulary Cancer Drugs Fund Risdiplam 
08.02.03 Non Formulary Cancer Drugs Fund Rituximab MabThera
08.02.03 Formulary Cancer Drugs Fund Rituximab Truxima
08.02.03 Formulary Cancer Drugs Fund Rituximab MabThera
10.01.03 Formulary Cancer Drugs Fund Rituximab (rheumatology) 
09.01.04 Formulary Cancer Drugs Fund Romiplostim 
08.01.05 Formulary Cancer Drugs Fund Rucaparib Rubraca
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib Jakavi
09.08.01 Non Formulary Cancer Drugs Fund Sapropterin Dihydrochloride  Kuvan
10.01.03 Formulary Cancer Drugs Fund Secukinumab Rheumatology
13.05.03 Formulary Cancer Drugs Fund Secukinumab 
09.05.02.02 Restricted Use Cancer Drugs Fund Sevelamer Carbonate Renvela
09.05.02.02 Formulary Cancer Drugs Fund Sevelamer Hydrochloride  
08.02.04 Non Formulary Cancer Drugs Fund Siponimod Mayzent
20 Non Formulary Cancer Drugs Fund Sipuleucel- T 
08.02.02 Formulary Cancer Drugs Fund Sirolimus Rapamune
04.01.01 Non Formulary Cancer Drugs Fund Sodium Oxybate 
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir Sovaldi
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir and Velpatasvir Epclusa
06.05.01 Formulary Cancer Drugs Fund Somatropin 
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent
08.02.02 Formulary Cancer Drugs Fund Tacrolimus Prograf
08.02.02 Formulary Cancer Drugs Fund Tacrolimus 
08.02.02 Formulary Cancer Drugs Fund Tacrolimus  AdoPORT
08.02.02 Formulary Cancer Drugs Fund Tacrolimus Advagraf
08.02.02 Formulary Cancer Drugs Fund Tacrolimus Modigraf
08.01.05 Formulary Cancer Drugs Fund Talimogene laherparepvec Imlygic
20 Non Formulary Cancer Drugs Fund Taribavirin 
01.04.02 Restricted Use Cancer Drugs Fund Teduglutide 
08.01.03 Non Formulary Cancer Drugs Fund Tegafur with Uracil Uftoral
06.07 Formulary Cancer Drugs Fund Temozolomide 
08.01.05 Formulary Cancer Drugs Fund Temozolomide Temodal
08.01.05 Non Formulary Cancer Drugs Fund Temsirolimus Torisel
05.03.03.01 Formulary Cancer Drugs Fund Tenofovir Disproxil 
08.02.04 Formulary Cancer Drugs Fund Teriflunomide Aubagio
06.06.01 Formulary Cancer Drugs Fund Teriparatide 
20 Non Formulary Cancer Drugs Fund TETRAHYDROBIOPTERIN Tablets 10 mg 
08.02.04 Formulary Cancer Drugs Fund Thalidomide Celgene
08.01.01 Formulary Cancer Drugs Fund Thiotepa 
13.05.03 Formulary Cancer Drugs Fund Tildrakizumab Dermatology
08.01.03 Formulary Cancer Drugs Fund Tioguanine Lanvis
05.01.04 Formulary Cancer Drugs Fund Tobramycin 
05.01.04 Formulary Cancer Drugs Fund Tobramycin inhaler TOBI Podhaler
10.01.03 Formulary Cancer Drugs Fund Tocilizumab 
01.05.03 Formulary Cancer Drugs Fund Tofacitinib Gastroenterology
10.01.03 Formulary Cancer Drugs Fund Tofacitinib citrate 
06.05.02 Formulary Cancer Drugs Fund Tolvaptan Samsca
06.05.02 Formulary Cancer Drugs Fund Tolvaptan Jinarc
08.01.05 Formulary Cancer Drugs Fund Topotecan Hycamtin
08.01.05 Formulary Cancer Drugs Fund Trabectedin Yondelis
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist
08.01.05 Formulary Cancer Drugs Fund Trastuzumab Herceptin
08.01.05 Formulary Cancer Drugs Fund Trastuzumab deruxtecan Enhertu
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla
08.01.01 Formulary Cancer Drugs Fund Treosulfan 
20 Non Formulary Cancer Drugs Fund Treprostinil  
08.01.05 Formulary Cancer Drugs Fund Tretinoin Vesanoid
08.01.05 Formulary Cancer Drugs Fund Trifluridine-tipiracil Lonsurf
08.03.04.02 Formulary Cancer Drugs Fund Triptorelin Decapeptyl
08.03.04.02 Formulary Cancer Drugs Fund Triptorelin Gonapeptyl Depot
10.01.03 Formulary Cancer Drugs Fund Upadacitinib 
01.05.03 Formulary Cancer Drugs Fund Ustekinumab Gastroenterology
10.01.03 Formulary Cancer Drugs Fund Ustekinumab rheumatology
13.05.03 Formulary Cancer Drugs Fund Ustekinumab 
05.03.02.02 Formulary Cancer Drugs Fund Valganciclovir 
08.01.05 Formulary Cancer Drugs Fund Vandetanib Caprelsa
01.05.03 Formulary Cancer Drugs Fund Vedolizumab 
08.01.05 Formulary Cancer Drugs Fund Vemurafenib Zelboraf
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto
08.01.04 Formulary Cancer Drugs Fund Vincristine Sulphate Oncovin
08.01.04 Non Formulary Cancer Drugs Fund Vinflunine Javlor
08.01.04 Formulary Cancer Drugs Fund Vinorelbine Navelbine
08.01.05 Non Formulary Cancer Drugs Fund Vismodegib Erivedge
02.12 Non Formulary Cancer Drugs Fund Volanesorsen Waylivra
09.01.05 Formulary Cancer Drugs Fund Vonicog alfa Veyvondi
11.99.99.99 Restricted Use Cancer Drugs Fund Voretigene neparvovec Luxturna
Shropshire and Telford Local Health Economy